Plasma thioredoxin reductase: a potential diagnostic biomarker for gastric cancer

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Clinical application of thioredoxin reductase as a novel biomarker in liver cancer

(2021) Xuping Wu et al.   Scientific Reports

HER2-targeted therapies in gastric cancer

(2021) Yinxing Zhu et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

AFP and eGFR are related to early and late recurrence of HCC following antiviral therapy

(2021) Takao Watanabe et al.   BMC CANCER

How to approach pancreatic cancer after neoadjuvant treatment: assessment of resectability using multidetector CT and tumor markers

(2021) Sun Kyung Jeon et al.   EUROPEAN RADIOLOGY

Noninvasive Detection of Hepatocellular Carcinoma with Circulating Tumor DNA Features and α-Fetoprotein

(2021) Zuowei Meng et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

CDH1 Gene Mutation Hereditary Diffuse Gastric Cancer Outcomes: Analysis of a Large Cohort, Systematic Review of Endoscopic Surveillance, and Secondary Cancer Risk Postulation

(2021) Matthew G. K. Benesch et al.   Cancers

PGC-1α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism

(2020) Sergio Rius-Pérez et al.   Oxidative Medicine and Cellular Longevity

Thioredoxin Reductase as a Novel and Efficient Plasma Biomarker for the Detection of Non-Small Cell Lung Cancer: a Large-scale, Multicenter study

(2019) Suofu Ye et al.   Scientific Reports

Multiple cytokine profiling in serum for early detection of gastric cancer

(2018) Jian Li et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Novel Gold(I) Thiolate Derivatives Synergistic with 5-Fluorouracil as Potential Selective Anticancer Agents in Colon Cancer

(2017) Elena Atrián-Blasco et al.   INORGANIC CHEMISTRY

The serum activity of thioredoxin reductases 1 (TrxR1) is correlated with the poor prognosis in EGFR wild-type and ALK negative non-small cell lung cancer

(2017) Gong Chen et al.   Oncotarget

Helicobacter pylori Vacuolating Toxin and Gastric Cancer

(2017) Mark McClain et al.   Toxins

TXNRD1 Is an Unfavorable Prognostic Factor for Patients with Hepatocellular Carcinoma

(2017) Binsheng Fu et al.   Biomed Research International

Gastric cancer

(2016) Eric Van Cutsem et al.   LANCET

Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma

(2016) Wei Wang et al.   Oncotarget

Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer

(2015) Li-Kui Yin et al.   Asian Pacific Journal of Cancer Prevention

Preoperative Serum CEA and CA19-9 in Gastric Cancer - a Single Tertiary Hospital Study of 1,075 Cases

(2015) Yang-Chun Zhou et al.   Asian Pacific Journal of Cancer Prevention

Thioredoxin reductase: A novel, independent prognostic marker in patients with hepatocellular carcinoma

(2015) Chunyan Li et al.   Oncotarget

Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer

(2013) Chao-Zhu He et al.   BMC GASTROENTEROLOGY

The thioredoxin antioxidant system

(2013) Jun Lu et al.   FREE RADICAL BIOLOGY AND MEDICINE

Thioredoxin System in Cell Death Progression

(2012) Jun Lu et al.   ANTIOXIDANTS & REDOX SIGNALING

Thioredoxin and thioredoxin reductase: Current research with special reference to human disease

(2010) Arne Holmgren et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS